Πλοήγηση ανά Συγγραφέα "Renaudineau, Y."
-
Anti-a actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1
Zachou, K.; Oikonomou, K.; Renaudineau, Y.; Chauveau, A.; Gatselis, N.; Youinou, P.; Dalekos, G. N. (2012)Background We reported that combined presence of autoantibodies (Abs) against filamentous-actin (AFA) and a-actinin are specific for autoimmune hepatitis type 1 (AIH-1) diagnosis. Aim To explore our data and assess whether ... -
ANTI-alpha ACTININ ANTIBODIES ARE INDEPENDENT PREDICTORS OF RESPONSE TO TREATMENT IN AUTOIMMUNE HEPATITIS TYPE 1
Zachou, K.; Renaudineau, Y.; Chauveau, A.; Youinou, P.; Dalekos, G. N. (2010) -
Anti-alpha-actinin antibodies cross-react with Anti-ssDNA antibodies in active autoimmune hepatitis
Renaudineau, Y.; Dalekos, G. N.; Gueguen, P.; Zachou, K.; Youinou, P. (2008)Recently, we have observed that the association of anti-F-actin autoantibodies (Abs) with anti-alpha-actinin Abs (double reactivity) was correlated with liver disease activity in autoimmune hepatitis type 1 (AIH-1; Gueguen ... -
Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis
Zachou, K.; Gampeta, S.; Gatselis, N. K.; Oikonomou, K.; Goulis, J.; Manoussakis, M. N.; Renaudineau, Y.; Bogdanos, D. P.; Dalekos, G. N. (2015)Background & AimsAntibodies (Abs) to soluble liver antigen/liver pancreas (anti-SLA/LP) are considered markers of worse prognosis and outcome in patients with autoimmune hepatitis (AIH) although this assumption has recently ... -
Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1
Gueguen, P.; Dalekos, G.; Nousbaum, J. B.; Zachou, K.; Putterman, C.; Youinou, P.; Renaudineau, Y. (2006)Anti-filamentous actin antibodies characterize autoimmune hepatitis type 1 (AIH-1). Recently, the binding domain of alpha-actinin on actin was shown to be a predominant epitope. To test this reactivity, an anti-alpha-actinin ...